
Northwestern Medicine scientists have identified an enzyme which aids tumors in evading the immune system, findings that could provide future directions for tumor treatment, according to a study published in Nature Communications.

Northwestern University scientists have discovered it is possible to isolate a tumor’s attack cells non-invasively from blood, rather than from tumors.

Repeat radiation therapy combined with monoclonal antibody treatment extended progression-free survival in patients with recurrent glioblastoma, according to a recent clinical trial published in the Journal of Clinical Oncology.

Two therapeutic drugs benefited mice with non-small cell lung cancer, potentially paving the way for clinical trials in humans.

Patients with advanced-stage melanoma who received immunotherapy both before and after surgery had longer event-free survival than patients who received immunotherapy only after surgery, according to a recent clinical trial published in the New England Journal of Medicine.

Combining a new hormone therapy drug with chemotherapy and another hormone therapy increased overall survival in patients with high-volume and both high-risk and low-risk metastatic hormone-sensitive prostate cancer, according to a post hoc analysis published in the Journal of Clinical Oncology.

Northwestern Medicine scientists have identified a new compound which could inform future HIV cure strategies, according to research published in Science Advances.

Northwestern Medicine scientists have developed a new tool to predict the risk of venous thromboembolism in patients with adult-type diffuse gliomas.

Northwestern Medicine scientists have uncovered a mechanism by which exercise activates metabolic benefits in the body, according to a new study published in Cell Metabolism.

People with sickle cell disease who receive nonmyeloablative stem cell transplants are at greater risk for developing new tumors, according to a new study published in the Journal of Clinical Oncology.